GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kodiak Sciences Inc (STU:K27) » Definitions » Other Current Payables

Kodiak Sciences (STU:K27) Other Current Payables : €0.00 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Kodiak Sciences Other Current Payables?

Kodiak Sciences's Other Current Payables for the quarter that ended in Mar. 2024 was €0.00 Mil.


Kodiak Sciences Other Current Payables Historical Data

The historical data trend for Kodiak Sciences's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kodiak Sciences Other Current Payables Chart

Kodiak Sciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Payables
Get a 7-Day Free Trial - - - - -

Kodiak Sciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Kodiak Sciences Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.


Kodiak Sciences Other Current Payables Related Terms

Thank you for viewing the detailed overview of Kodiak Sciences's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.


Kodiak Sciences (STU:K27) Business Description

Traded in Other Exchanges
Address
1200 Page Mill Road, Palo Alto, CA, USA, 94304
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.

Kodiak Sciences (STU:K27) Headlines

No Headlines